P
Philippe Maingon
Researcher at University of Paris
Publications - 261
Citations - 17363
Philippe Maingon is an academic researcher from University of Paris. The author has contributed to research in topics: Radiation therapy & Prostate cancer. The author has an hindex of 49, co-authored 238 publications receiving 14930 citations. Previous affiliations of Philippe Maingon include European Organisation for Research and Treatment of Cancer & Radboud University Nijmegen.
Papers
More filters
Journal ArticleDOI
Postoperative Irradiation With or Without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
Jacques Bernier,Christian Domenge,Mahmut Ozsahin,Katarzyna Matuszewska,Jean-Louis Lefebvre,Richard H. Greiner,Jordi Giralt,Philippe Maingon,Frederic Rolland,M. Bolla,Francesco Cognetti,Jean Bourhis,Anne Kirkpatrick,Martine Van Glabbeke +13 more
TL;DR: Postoperative concurrent administration of high-dose cisplatin with radiotherapy is more efficacious than radiotherapy alone in patients with locally advanced head and neck cancer and does not cause an undue number of late complications.
Journal ArticleDOI
Chemotherapy with preoperative radiotherapy in rectal cancer
Jean-François Bosset,Laurence Collette,Gilles Calais,Laurent Mineur,Philippe Maingon,L. Radosevic-Jelic,Alain Daban,Etienne Bardet,Alexander Beny,Jean-Claude Ollier +9 more
TL;DR: In patients with rectal cancer who receive preoperative radiotherapy, adding fluorouracil-based chemotherapy preoperatively or postoperatively has no significant effect on survival.
Journal ArticleDOI
Internal mammary and medial supraclavicular irradiation in breast cancer
P. Poortmans,Sandra Collette,C. Kirkove,E. Van Limbergen,Volker Budach,H. Struikmans,Laurence Collette,A. Fourquet,Philippe Maingon,M.C. Valli,K. De Winter,Simone Marnitz,Isabelle Barillot,L. Scandolaro,Ernest Vonk,Carla C. Rodenhuis,Hugo Marsiglia,N. Weidner,G. van Tienhoven,C. Glanzmann,Abraham Kuten,Rodrigo Arriagada,Harry Bartelink,W. Van den Bogaert +23 more
TL;DR: In patients with early-stage breast cancer, irradiation of the regional nodes had a marginal effect on overall survival, disease-free survival and distant disease- free survival were improved, and breast-cancer mortality was reduced.
Journal ArticleDOI
CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.
Vincent Grégoire,Peter C. Levendag,Kian K. Ang,Jacques Bernier,Marijel Braaksma,Volker Budach,Cliff Chao,Emmanuel Coche,Jay S. Cooper,Guy Cosnard,Avraham Eisbruch,Samy El-Sayed,Bahman Emami,Cai Grau,Marc Hamoir,Nancy Y. Lee,Philippe Maingon,Karin Muller,Hervé Reychler +18 more
TL;DR: The objective of the present article is to present the consensus guidelines for the delineation of the node levels in the node-negative neck, and representative CTVs that are consistent with these guidelines are illustrated on CT sections.
Journal ArticleDOI
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
Bruno Chauffert,F. Mornex,Franck Bonnetain,Ph. Rougier,Christophe Mariette,O. Bouche,J.-F. Bosset,Thomas Aparicio,Laurent Mineur,A. Azzedine,Pascal Hammel,J. Butel,N. Stremsdoerfer,Philippe Maingon,Laurent Bedenne +14 more
TL;DR: This intensive induction schedule of CHRT was more toxic and less effective than gemcitabine alone and was confirmed in a per-protocol analysis for patients who received 75% or more of the planned dose of radiotherapy.